National Chemical Laboratory has 7% staff and relatives Seropositive at Pune

▴ National Chemical Laboratory has 7% staff and relatives Seropositive at Pune
In an internal Covid audit under Phenome India revealed the stats

A seropositive rate of 7 per cent was revealed in serological tests conducted by the CSIR- National Chemical Laboratory (NCL) among its staff and family members.
A serological test reveals if a person has developed antibodies to the coronavirus, a positive result indicating that he/she has already been exposed to the virus.

"Among 339 participants, 18 men and six women were found to be seropositive, which accounts for about 7 per cent of the total sample. These comprise 19 students, 3 contract staff and 2 family members," an official said.

The study was part of a project led by the Council of Scientific and Industrial Research (CSIR)-Institute of Genomics and Integrative Biology. This initiative was a part of the PAN India project named ‘Phenome India initiated by Council of Scientific and Industrial Research (CSIR) and led by Delhi-based CSIR- Institute of Genomics and Integrative Biology and Dr. Shantanu Sengupta from CSIR-IGIB is coordinating. This research study involves testing of antibodies against SARS-CoV-2 in the people working in the CSIR labs and their family members under "Phenome India - A long-term longitudinal observational cohort study of health outcomes." The CSIR-NCL and CSIR-URDIP represent the western region.

The CSIR-NCL team comprises scientists from the Biochemical Sciences Division and doctors from the Medical Centre. The serological testing at The CSIR-NCL started on 12 September 2020 at NCL Medical Center and concluded on 24th September. The blood samples along with the health data will be sent to CSIR-IGIB for serological analysis. Blood samples are being collected from those who are willing to participate. The test is voluntary and open to all CSIR staff, including pensioners (up to the age of 70 yr), students, contractual staff and their families (aged 18 yrs and above). 

Tags : #PhenomeIndia #NationalChemicalLaboratoryPune #CSIR-NCL #LatestPuneCovidNewsUpdateSep26 #LatestSeropostiveNewsSep26 #IndiaCovidNewsUpdateSep26

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

To stay well during festive seasonOctober 21, 2020
The fastest growing and the most awarded Cath Lab of India in 2018 is bringing affordable and accessible healthcare available for cardiovascular diseases in India saOctober 21, 2020
ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptionsOctober 21, 2020
No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study October 21, 2020
India sustains the continued trend of consistent decline in Active CasesOctober 21, 2020
Lifeness Science Institute by Luke Coutinho Introduces Programmes in Integrative Nutrition and DieteticsOctober 21, 2020
Lifeness Science Institute by Luke Coutinho Introduces Programmes in Integrative Nutrition and DieteticsOctober 21, 2020
Haryana tops Anemia Mukt Bharat Index in countryOctober 21, 2020
Covid Update: Assam & OdishaOctober 21, 2020
BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMT™October 21, 2020
Teladoc Health Data Shows Broadening Mental Health Care DemandOctober 21, 2020
China vaccinated 60,000 people: Result awaited October 21, 2020
Lilly hires outside advisor for COVID drug plant problemsOctober 21, 2020
No Child Mothers, Accelerating the reduction of adolescent pregnancies on occasion of Adolescent Pregnancy Prevention Week October 21, 2020
Tyber Medical receives US FDA clearance on foot and ankle plating systemsOctober 21, 2020
Green tea and coffee connected to lower death risk in people with diabetesOctober 21, 2020
MEDICAL FESTIVAL ASIA: Events for the region’s medical and healthcare sectorOctober 21, 2020
Selecta Biosciences and Asklepios BioPharmaceutical receives US FDA approval for their gene therapyOctober 21, 2020
Astellas Pharma received US FDA approval for the treatment of primary mitochondrial myopathiesOctober 21, 2020
GSK presents positive clinical data on maternal and older adults RSV candidate vaccinesOctober 21, 2020